v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | EUCTR2020-001549-38-DE |
Full text link
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001549-38/DE |
First author
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
|
Contact
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
i.puentmann@pharmakologie-bremen.de |
Registration date
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
2020-04-06 |
Recruitment status
Last imported at : June 17, 2021, 1:30 a.m. Source : EU Clinical Trials Register |
Terminated |
Study design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Randomized |
Design
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Open label |
Center
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
multi-center |
Study aim
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Treatment |
Inclusion criteria
Last imported at : Nov. 10, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
Patients 18 years and older SARS-CoV-2 infection confirmed by PCR in any specimen < 9 days prior to randomization Admitted to the hospital ward or the ICU due to COVID-19 SpO2 ≤ 94% on room air OR oxygen demand OR breathing support Written informed consent obtained |
Exclusion criteria
Last imported at : Nov. 10, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
Patient's non-consent or inability to informed consent Pregnant or breastfeeding women Subjects pretreated with one of the active study drugs in the past 29 days Anticipated transfer within 72 hours to a non-study hospital Severe co-morbidity with life expectancy < 3 months according to investigators opinion AST or ALT > 5 times the upper limit of normal Stage 4 severe chronic kidney disease or requiring dialysis (i.e. eGFR < 30 mL/min) Contraindications to any of the active study drugs Subjects participating in a potentially confounding drug or device trial during the course of the study in the last 29 days Any reason why, in the opinion of the investigators, the patient should not participate |
Number of arms
Last imported at : Nov. 10, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
2 |
Funding
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Gesundheit Nord gGmbH |
Inclusion age min
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
100 |
Countries
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Germany |
Type of patients
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Severe disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
6: Severe disease at enrollment |
Total sample size
Last imported at : Nov. 10, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
400 |
primary outcome
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
improvement of the clinical status on the ordinal 7-point severity-scale at day 15: 1. Not hospitalized, no limitations on activities, 2. Not hospitalized, limitation on activities, 3. Hospitalized, not requiring supplemental oxygen, 4. Hospitalized, requiring supplemental oxygen, 5. Hospitalized, on non-invasive ventilation or high flow oxygen devices, 6. Hospitalized, on invasive mechanical ventilation or ECMO, 7. Death |
Notes
Last imported at : Nov. 10, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
Declared number of arm (2.0) differs from found arms (1.0) |
Phase
Last imported at : Oct. 26, 2020, 7:26 a.m. Source : EU Clinical Trials Register |
Phase 3 |
Arms
Last imported at : Nov. 10, 2020, 12:30 a.m. Source : EU Clinical Trials Register |
[{"arm_notes": "", "treatment_id": 1099, "treatment_name": "Remdesivir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}] |